OncoDaily IO
@OncoDailyIO
Followers
2K
Following
4K
Media
382
Statuses
915
Your daily source for the latest updates, insights, and news in immuno-oncology. #OncoDailyIO #OncoDaily #immunooncology #immuneoncology #immunotherapy
Boston, MA, USA
Joined September 2024
Nicola Ferrari Highlights Study on Allogeneic CD19 CAR-T Cells for Refractory Lupus Nephritis. #Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
1
4
Comparative Study of Daratumumab Regimens in Myeloma - Muhammad Umair Mushtaq (@mumairmushtaq). #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology #Daratumumab #MM #Myeloma
0
2
9
Can We Spare Surgery and Radiation for Some CSCC Patients? - Andrea Boutros (@boutrosand). #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology #CSCC
0
1
10
Studying Stem Cell Mobilization in the CD38-mAb Era - Lekha Mikkilineni (@LMikkMD). #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
0
1
8
๐ฌ ๐๐ฎ๐ป ๐๐บ๐บ๐๐ป๐ผ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ ๐ง๐ฟ๐ฒ๐ฎ๐ ๐ ๐ฆ๐ฆ ๐๐ผ๐น๐ผ๐ฟ๐ฒ๐ฐ๐๐ฎ๐น ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ? ๐ฌ. In our latest OncoDaily IO interview, ๐๐ฟ. ๐๐ฒ๐ป๐ท๐ฎ๐บ๐ถ๐ป ๐ฆ๐ฐ๐ต๐น๐ฒ๐ฐ๐ต๐๐ฒ๐ฟ from Dana-Farber Cancer Institute discusses the IO combination of ๐ฏ๐ผ๐๐ฒ๐ป๐๐ถ๐น๐ถ๐บ๐ฎ๐ฏ (๐๐ง๐๐-๐ฐ)
0
5
20
๐ ๐ง๐ผ๐ฝ ๐ญ๐ฌ ๐ ๐๐๐-๐ฅ๐ฒ๐ฎ๐ฑ ๐จ๐ฝ๐ฑ๐ฎ๐๐ฒ๐ ๐ถ๐ป ๐๐บ๐บ๐๐ป๐ผ-๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ ๐ง๐ต๐ถ๐ ๐ช๐ฒ๐ฒ๐ธ. This Weekโs Spotlight by OncoDaily Immuno-Oncology. From groundbreaking research on FOXP3 isoforms to advancements in tumor-infiltrating lymphocyte (TIL) therapy for melanoma
0
8
16
Initial Data on IL-18 CD371 CAR T in AML - Omar Abdel-Wahab. @AbdelWahablab @DaniyanMd @MSKCancerCenter . #Immunotherapy #ImmuneOnc #CD371 #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
0
3
Interim Results of Sunrise4 are Releasedย in The Lancet Oncology - @AndreaNecchi . @BrigidaMaiorano . #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
0
9
NK cells matter! @DrPatSoonShiong . @ImmunityBio @oncodaily . #patricksoonshiong #cancer #lcsm #lungcancer #oncology #oncodaily #immunitybio #immunotherapy #nkcells #bioshield
0
2
14
Surprising Benefits of Adjuvant Abemaciclib in Breast Cancer Treatment. @JAMouabbi @stolaney1 . #Immunotherapy #CancerTreatment #BreastCancer #BCSM #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
3
5
18
Herbert Loong Attends Lung Cancer Preceptorship in Manila. @herbloong @AstraZeneca @KSamalaMD @AlbertaUni. #LungCancer #LCSM #IO #EGFR #PSMO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
1
10
Mark Yarchoan Highlights Study on Timing of ICI for Improved NSCLC Outcomes. @MarkYarchoan . #Immunotherapy #NSCLC #CancerOutcomes #LungCancer #LCSM #ICI #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
1
9
Katherine Van Loon Shared Impactful Commentary on Barriers to ICIs Access in Southeast Asia. @KVanLoonMD @JCOGO_ASCO @EChrisDee . #ICI #Immunotherapy #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
2
11
Stephen Liu Praises Dr. Jennifer Kanakryโs Presentation on Cellular Therapy. @StephenVLiu @Georgetown @BMTDocJenK . #CellularTherapy #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
1
8
Sara Tolaney Leads A012103 Trial to Compare Pembrolizumab to Observation in TNBC. @ALLIANCE_org @DanaFarber . #TNBC #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
2
13
James Crowley Highlights John DiPersio Immunotherapy Symposium on AML and CAR T. #Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
1
9
Yan Leyfman Highlights Breakthrough Study on Bispecific Antibodies in CNS Myeloma. @YLeyfman . #CNSMyeloma #BispecificAntibodies #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
1
1
15
Alberto Servetto Highlights High Early Censoring Rates in Immunotherapy Studies. @vitale_filippo @MassimoDiMaio75 . #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
1
2
11
Arndt Vogel Shares Phase 1/2 Trial Results on Encorafenib, Cetuximab, and Nivolumab in mCRC. @ArndtVogel. #mCRC #ColorectalCancer #GIOnc #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
0
2
14
Reviewing the Role of Immunotherapy in Colorectal Cancers and Other Solid Tumors - @gagan_brar24 . #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
0
1
8